164 related articles for article (PubMed ID: 17103462)
1. The C-peptide fragment EVARQ reduces glomerular hyperfiltration in streptozotocin-induced diabetic rats.
Nordquist L; Moe E; Sjöquist M
Diabetes Metab Res Rev; 2007 Jul; 23(5):400-5. PubMed ID: 17103462
[TBL] [Abstract][Full Text] [Related]
2. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Ekberg K; Isaksson B; Eriksson L; Wahren J; Sjöquist M
Nephrol Dial Transplant; 2005 Mar; 20(3):532-8. PubMed ID: 15665028
[TBL] [Abstract][Full Text] [Related]
3. C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats.
Samnegård B; Jacobson SH; Johansson BL; Ekberg K; Isaksson B; Wahren J; Sjöquist M
Nephrol Dial Transplant; 2004 Jun; 19(6):1385-91. PubMed ID: 15004258
[TBL] [Abstract][Full Text] [Related]
4. Human C-peptide acutely lowers glomerular hyperfiltration and proteinuria in diabetic rats: a dose-response study.
Huang DY; Richter K; Breidenbach A; Vallon V
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):67-73. PubMed ID: 11862335
[TBL] [Abstract][Full Text] [Related]
5. Effect of aspirin on experimental diabetic nephropathy.
Moel DI; Safirstein RL; McEvoy RC; Hsueh W
J Lab Clin Med; 1987 Sep; 110(3):300-7. PubMed ID: 3475395
[TBL] [Abstract][Full Text] [Related]
6. Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats.
Kamikawa A; Ishii T; Shimada K; Makondo K; Inanami O; Sakane N; Yoshida T; Saito M; Kimura K
Diabetes Metab Res Rev; 2008; 24(4):331-8. PubMed ID: 18088079
[TBL] [Abstract][Full Text] [Related]
7. Disparate effects of castration on renal structure and function in the streptozotocin diabetic rat.
Bach LA; Cooper ME; Vranes D; Allen TJ; Rumble J; Jerums G
Diabetes Res; 1994; 27(1):27-38. PubMed ID: 7648794
[TBL] [Abstract][Full Text] [Related]
8. Influence of C-peptide on early glomerular changes in diabetic mice.
Maezawa Y; Yokote K; Sonezaki K; Fujimoto M; Kobayashi K; Kawamura H; Tokuyama T; Takemoto M; Ueda S; Kuwaki T; Mori S; Wahren J; Saito Y
Diabetes Metab Res Rev; 2006; 22(4):313-22. PubMed ID: 16389646
[TBL] [Abstract][Full Text] [Related]
9. Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking the tubuloglomerular feedback mechanism.
Sällström J; Carlsson PO; Fredholm BB; Larsson E; Persson AE; Palm F
Acta Physiol (Oxf); 2007 Jul; 190(3):253-9. PubMed ID: 17581137
[TBL] [Abstract][Full Text] [Related]
10. C-peptide normalizes glomerular filtration rate in hyperfiltrating conscious diabetic rats.
Stridh S; Sällström J; Fridén M; Hansell P; Nordquist L; Palm F
Adv Exp Med Biol; 2009; 645():219-25. PubMed ID: 19227475
[TBL] [Abstract][Full Text] [Related]
11. Effect of experimental diabetes on glomerular filtration rate and glomerular prostanoid production in the rat.
Kirschenbaum MA; Chaudhari A
Miner Electrolyte Metab; 1986; 12(5-6):352-5. PubMed ID: 3807832
[TBL] [Abstract][Full Text] [Related]
12. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats.
Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Sjöquist M
Kidney Int; 2001 Oct; 60(4):1258-65. PubMed ID: 11576340
[TBL] [Abstract][Full Text] [Related]
13. [Prevention by L-dopa of early renal consequences of diabetes induced by streptozocin in rats].
Vailly B; Barthelmebs M; Velly J; Grima M; Imbs JL
Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1259-62. PubMed ID: 2148079
[TBL] [Abstract][Full Text] [Related]
14. Effect of KATP channel blocker U37883A on renal function in experimental diabetes mellitus in rats.
Vallon V; Albinus M; Blach D
J Pharmacol Exp Ther; 1998 Sep; 286(3):1215-21. PubMed ID: 9732381
[TBL] [Abstract][Full Text] [Related]
15. Antagonist for atrial natriuretic peptide receptors ameliorates glomerular hyperfiltration in diabetic rats.
Kikkawa R; Haneda M; Sakamoto K; Koya D; Shikano T; Nakanishi S; Matsuda Y; Shigeta Y
Biochem Biophys Res Commun; 1993 Jun; 193(2):700-5. PubMed ID: 8390251
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin prevents early steps of the development of diabetic nephropathy in rats.
Yang Y; Wang J; Qin L; Shou Z; Zhao J; Wang H; Chen Y; Chen J
Am J Nephrol; 2007; 27(5):495-502. PubMed ID: 17671379
[TBL] [Abstract][Full Text] [Related]
17. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
[TBL] [Abstract][Full Text] [Related]
18. Effects of C-peptide on renal function at the early stage of experimental diabetes.
Sjöquist M; Huang W; Johansson BL
Kidney Int; 1998 Sep; 54(3):758-64. PubMed ID: 9734600
[TBL] [Abstract][Full Text] [Related]
19. In vivo quantitative visualization analysis of the effect of C-peptide on glomerular hyperfiltration in diabetic rats by using multiphoton microscopy.
Nakamoto H; Kajiya F
Microcirculation; 2013 Jul; 20(5):425-33. PubMed ID: 24003455
[TBL] [Abstract][Full Text] [Related]
20. Effect of L-dopa decarboxylase inhibitor benserazide on renal function in streptozotocin-diabetic rats.
Pfeil K; Staudacher T; Luippold G
Kidney Blood Press Res; 2006; 29(1):43-7. PubMed ID: 16636577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
